AlgaVac’s technology was successfully validated by global companies and research institutes
Virbac – a leading multinational animal health company, conducted POC trial for AlgaVac’s oral fish vaccine which successfully demonstrated significant survival rate of vaccinated fish. Subsequently, Virbac and AlgaVac have reached an agreement to develop and commercialize two oral fish vaccines, based on the algal platform.
Collaboration with Temasek Polytechnic from Singapore resulted in a successful POC for the iridovirus oral fish vaccine, demonstrating significant survival rate of fish vaccinated, through feeding, with the algal powder.
Collaboration with the Agriculture Research Organization (ARO) in Israel resulted in a successful POC for oral fish growth promoting agent, demonstrating significant increase in fish growth rate and fish survival.
Skip to content